nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—CYP1A1—Cholecalciferol—osteoporosis	0.128	0.183	CbGbCtD
Mebendazole—CYP1A1—Estradiol—osteoporosis	0.103	0.147	CbGbCtD
Mebendazole—ABCB1—Ethinyl Estradiol—osteoporosis	0.0624	0.0893	CbGbCtD
Mebendazole—CYP3A4—Estropipate—osteoporosis	0.058	0.083	CbGbCtD
Mebendazole—CYP3A4—Calcitriol—osteoporosis	0.058	0.083	CbGbCtD
Mebendazole—CYP3A4—Ergocalciferol—osteoporosis	0.0464	0.0664	CbGbCtD
Mebendazole—ABCB1—Conjugated Estrogens—osteoporosis	0.0458	0.0655	CbGbCtD
Mebendazole—ABCB1—Estradiol—osteoporosis	0.0402	0.0575	CbGbCtD
Mebendazole—CYP3A4—Raloxifene—osteoporosis	0.0387	0.0554	CbGbCtD
Mebendazole—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0374	0.0535	CbGbCtD
Mebendazole—CYP3A4—Cholecalciferol—osteoporosis	0.0299	0.0428	CbGbCtD
Mebendazole—CYP3A4—Conjugated Estrogens—osteoporosis	0.0274	0.0393	CbGbCtD
Mebendazole—CYP3A4—Estradiol—osteoporosis	0.0241	0.0345	CbGbCtD
Mebendazole—TUBA1A—Formation of tubulin folding intermediates by CCT/TriC—CCT2—osteoporosis	0.0126	0.0631	CbGpPWpGaD
Mebendazole—TUBA1A—Post-chaperonin tubulin folding pathway—TUBA1B—osteoporosis	0.0116	0.0582	CbGpPWpGaD
Mebendazole—TUBA1A—Formation of tubulin folding intermediates by CCT/TriC—TUBA1B—osteoporosis	0.0107	0.0537	CbGpPWpGaD
Mebendazole—TUBA1A—Prefoldin mediated transfer of substrate to CCT/TriC—CCT2—osteoporosis	0.0103	0.0516	CbGpPWpGaD
Mebendazole—TUBA1A—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—CCT2—osteoporosis	0.01	0.0502	CbGpPWpGaD
Mebendazole—TUBA1A—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBA1B—osteoporosis	0.00852	0.0426	CbGpPWpGaD
Mebendazole—TUBB4B—Formation of tubulin folding intermediates by CCT/TriC—CCT2—osteoporosis	0.00762	0.0381	CbGpPWpGaD
Mebendazole—TUBB4B—Post-chaperonin tubulin folding pathway—TUBA1B—osteoporosis	0.00702	0.0351	CbGpPWpGaD
Mebendazole—TUBB4B—Formation of tubulin folding intermediates by CCT/TriC—TUBA1B—osteoporosis	0.00648	0.0324	CbGpPWpGaD
Mebendazole—TUBA1A—Chaperonin-mediated protein folding—CCT2—osteoporosis	0.0064	0.0321	CbGpPWpGaD
Mebendazole—TUBB4B—Prefoldin mediated transfer of substrate to CCT/TriC—CCT2—osteoporosis	0.00623	0.0312	CbGpPWpGaD
Mebendazole—TUBB4B—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—CCT2—osteoporosis	0.00605	0.0303	CbGpPWpGaD
Mebendazole—TUBA1A—Protein folding—CCT2—osteoporosis	0.00584	0.0292	CbGpPWpGaD
Mebendazole—TUBA1A—Chaperonin-mediated protein folding—TUBA1B—osteoporosis	0.00544	0.0273	CbGpPWpGaD
Mebendazole—TUBB4B—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBA1B—osteoporosis	0.00514	0.0258	CbGpPWpGaD
Mebendazole—TUBA1A—Pathogenic Escherichia coli infection—TUBA1B—osteoporosis	0.00496	0.0249	CbGpPWpGaD
Mebendazole—TUBA1A—Protein folding—TUBA1B—osteoporosis	0.00496	0.0249	CbGpPWpGaD
Mebendazole—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00477	0.0239	CbGpPWpGaD
Mebendazole—Menorrhagia—Ethinyl Estradiol—osteoporosis	0.00451	0.0446	CcSEcCtD
Mebendazole—TUBA1A—Parkin-Ubiquitin Proteasomal System pathway—TUBA1B—osteoporosis	0.00409	0.0205	CbGpPWpGaD
Mebendazole—TUBB4B—Chaperonin-mediated protein folding—CCT2—osteoporosis	0.00387	0.0194	CbGpPWpGaD
Mebendazole—TUBB4B—Protein folding—CCT2—osteoporosis	0.00353	0.0176	CbGpPWpGaD
Mebendazole—TUBA1A—Pathogenic Escherichia coli infection—ACTG1—osteoporosis	0.00344	0.0172	CbGpPWpGaD
Mebendazole—TUBB4B—Chaperonin-mediated protein folding—TUBA1B—osteoporosis	0.00329	0.0165	CbGpPWpGaD
Mebendazole—TUBB4B—Protein folding—TUBA1B—osteoporosis	0.003	0.015	CbGpPWpGaD
Mebendazole—TUBB4B—Pathogenic Escherichia coli infection—TUBA1B—osteoporosis	0.003	0.015	CbGpPWpGaD
Mebendazole—Menorrhagia—Estradiol—osteoporosis	0.00294	0.0291	CcSEcCtD
Mebendazole—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00294	0.0147	CbGpPWpGaD
Mebendazole—Agranulocytosis—Etidronic acid—osteoporosis	0.00249	0.0246	CcSEcCtD
Mebendazole—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—TUBA1B—osteoporosis	0.00247	0.0124	CbGpPWpGaD
Mebendazole—TUBB4B—Pathogenic Escherichia coli infection—ACTG1—osteoporosis	0.00208	0.0104	CbGpPWpGaD
Mebendazole—Hypersensitivity—Calcium Acetate—osteoporosis	0.00191	0.0189	CcSEcCtD
Mebendazole—Angioedema—Etidronic acid—osteoporosis	0.0019	0.0188	CcSEcCtD
Mebendazole—Neutropenia—Pamidronate—osteoporosis	0.00182	0.018	CcSEcCtD
Mebendazole—Neutropenia—Zoledronate—osteoporosis	0.00166	0.0164	CcSEcCtD
Mebendazole—Angioedema—Estropipate—osteoporosis	0.00165	0.0163	CcSEcCtD
Mebendazole—Angioedema—Alendronate—osteoporosis	0.00162	0.016	CcSEcCtD
Mebendazole—Agranulocytosis—Pamidronate—osteoporosis	0.00162	0.016	CcSEcCtD
Mebendazole—Angioedema—Ibandronate—osteoporosis	0.00158	0.0156	CcSEcCtD
Mebendazole—Agranulocytosis—Zoledronate—osteoporosis	0.00148	0.0146	CcSEcCtD
Mebendazole—TUBB4B—Orphan transporters—ANXA2—osteoporosis	0.00147	0.00735	CbGpPWpGaD
Mebendazole—Convulsion—Calcitriol—osteoporosis	0.00146	0.0145	CcSEcCtD
Mebendazole—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00139	0.0137	CcSEcCtD
Mebendazole—Urticaria—Etidronic acid—osteoporosis	0.00135	0.0134	CcSEcCtD
Mebendazole—Abdominal pain—Etidronic acid—osteoporosis	0.00134	0.0133	CcSEcCtD
Mebendazole—Angioedema—Ethinyl Estradiol—osteoporosis	0.00133	0.0132	CcSEcCtD
Mebendazole—Angioedema—Risedronate—osteoporosis	0.0013	0.0129	CcSEcCtD
Mebendazole—Hypersensitivity—Etidronic acid—osteoporosis	0.00125	0.0124	CcSEcCtD
Mebendazole—Angioedema—Pamidronate—osteoporosis	0.00124	0.0122	CcSEcCtD
Mebendazole—Gastrointestinal pain—Estropipate—osteoporosis	0.0012	0.0119	CcSEcCtD
Mebendazole—Gastrointestinal pain—Alendronate—osteoporosis	0.00118	0.0117	CcSEcCtD
Mebendazole—Convulsion—Pamidronate—osteoporosis	0.00117	0.0116	CcSEcCtD
Mebendazole—Urticaria—Estropipate—osteoporosis	0.00117	0.0116	CcSEcCtD
Mebendazole—Gastrointestinal pain—Raloxifene—osteoporosis	0.00116	0.0115	CcSEcCtD
Mebendazole—Abdominal pain—Estropipate—osteoporosis	0.00116	0.0115	CcSEcCtD
Mebendazole—Gastrointestinal pain—Ibandronate—osteoporosis	0.00115	0.0114	CcSEcCtD
Mebendazole—Urticaria—Alendronate—osteoporosis	0.00115	0.0114	CcSEcCtD
Mebendazole—Abdominal pain—Alendronate—osteoporosis	0.00114	0.0113	CcSEcCtD
Mebendazole—Angioedema—Zoledronate—osteoporosis	0.00113	0.0112	CcSEcCtD
Mebendazole—Gastrointestinal pain—Calcitriol—osteoporosis	0.00113	0.0112	CcSEcCtD
Mebendazole—Abdominal pain—Raloxifene—osteoporosis	0.00113	0.0111	CcSEcCtD
Mebendazole—Urticaria—Ibandronate—osteoporosis	0.00112	0.0111	CcSEcCtD
Mebendazole—Abdominal pain—Ibandronate—osteoporosis	0.00111	0.011	CcSEcCtD
Mebendazole—Urticaria—Calcitriol—osteoporosis	0.0011	0.0108	CcSEcCtD
Mebendazole—Hepatitis—Estradiol—osteoporosis	0.00109	0.0108	CcSEcCtD
Mebendazole—Abdominal pain—Calcitriol—osteoporosis	0.00109	0.0108	CcSEcCtD
Mebendazole—Angioedema—Conjugated Estrogens—osteoporosis	0.00109	0.0108	CcSEcCtD
Mebendazole—Hypersensitivity—Estropipate—osteoporosis	0.00108	0.0107	CcSEcCtD
Mebendazole—Rash—Etidronic acid—osteoporosis	0.00107	0.0106	CcSEcCtD
Mebendazole—Convulsion—Zoledronate—osteoporosis	0.00107	0.0106	CcSEcCtD
Mebendazole—Dermatitis—Etidronic acid—osteoporosis	0.00107	0.0106	CcSEcCtD
Mebendazole—Hypersensitivity—Alendronate—osteoporosis	0.00107	0.0106	CcSEcCtD
Mebendazole—Hypersensitivity—Ibandronate—osteoporosis	0.00104	0.0103	CcSEcCtD
Mebendazole—Convulsion—Conjugated Estrogens—osteoporosis	0.00103	0.0102	CcSEcCtD
Mebendazole—Hypersensitivity—Calcitriol—osteoporosis	0.00102	0.0101	CcSEcCtD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.000977	0.00489	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000974	0.00964	CcSEcCtD
Mebendazole—Gastrointestinal pain—Risedronate—osteoporosis	0.00095	0.0094	CcSEcCtD
Mebendazole—Urticaria—Ethinyl Estradiol—osteoporosis	0.000946	0.00936	CcSEcCtD
Mebendazole—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000942	0.00932	CcSEcCtD
Mebendazole—Rash—Estropipate—osteoporosis	0.000927	0.00917	CcSEcCtD
Mebendazole—Dermatitis—Estropipate—osteoporosis	0.000926	0.00916	CcSEcCtD
Mebendazole—Urticaria—Risedronate—osteoporosis	0.000923	0.00913	CcSEcCtD
Mebendazole—Abdominal pain—Risedronate—osteoporosis	0.000918	0.00908	CcSEcCtD
Mebendazole—Rash—Alendronate—osteoporosis	0.000913	0.00903	CcSEcCtD
Mebendazole—Dermatitis—Alendronate—osteoporosis	0.000912	0.00902	CcSEcCtD
Mebendazole—CYP1A1—Estrogen Receptor Pathway—ESR1—osteoporosis	0.000904	0.00453	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Pamidronate—osteoporosis	0.000903	0.00893	CcSEcCtD
Mebendazole—Rash—Raloxifene—osteoporosis	0.000897	0.00888	CcSEcCtD
Mebendazole—Dermatitis—Raloxifene—osteoporosis	0.000897	0.00887	CcSEcCtD
Mebendazole—Rash—Ibandronate—osteoporosis	0.000888	0.00879	CcSEcCtD
Mebendazole—Dermatitis—Ibandronate—osteoporosis	0.000888	0.00878	CcSEcCtD
Mebendazole—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000878	0.00868	CcSEcCtD
Mebendazole—Abdominal pain—Pamidronate—osteoporosis	0.000873	0.00864	CcSEcCtD
Mebendazole—Angioedema—Estradiol—osteoporosis	0.00087	0.00861	CcSEcCtD
Mebendazole—Rash—Calcitriol—osteoporosis	0.00087	0.00861	CcSEcCtD
Mebendazole—Dermatitis—Calcitriol—osteoporosis	0.000869	0.0086	CcSEcCtD
Mebendazole—Hypersensitivity—Risedronate—osteoporosis	0.000856	0.00847	CcSEcCtD
Mebendazole—Gastrointestinal pain—Zoledronate—osteoporosis	0.000825	0.00816	CcSEcCtD
Mebendazole—Hypersensitivity—Pamidronate—osteoporosis	0.000813	0.00805	CcSEcCtD
Mebendazole—Urticaria—Zoledronate—osteoporosis	0.000801	0.00793	CcSEcCtD
Mebendazole—Abdominal pain—Zoledronate—osteoporosis	0.000797	0.00789	CcSEcCtD
Mebendazole—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000794	0.00786	CcSEcCtD
Mebendazole—TUBA1A—Metabolism of proteins—CCT2—osteoporosis	0.000778	0.0039	CbGpPWpGaD
Mebendazole—Urticaria—Conjugated Estrogens—osteoporosis	0.000771	0.00763	CcSEcCtD
Mebendazole—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000768	0.0076	CcSEcCtD
Mebendazole—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000762	0.00382	CbGpPWpGaD
Mebendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000758	0.00379	CbGpPWpGaD
Mebendazole—Rash—Ethinyl Estradiol—osteoporosis	0.000751	0.00743	CcSEcCtD
Mebendazole—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00075	0.00742	CcSEcCtD
Mebendazole—CYP1A1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000748	0.00374	CbGpPWpGaD
Mebendazole—Hypersensitivity—Zoledronate—osteoporosis	0.000743	0.00735	CcSEcCtD
Mebendazole—Rash—Risedronate—osteoporosis	0.000732	0.00725	CcSEcCtD
Mebendazole—Dermatitis—Risedronate—osteoporosis	0.000732	0.00724	CcSEcCtD
Mebendazole—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000715	0.00708	CcSEcCtD
Mebendazole—Rash—Pamidronate—osteoporosis	0.000696	0.00689	CcSEcCtD
Mebendazole—Dermatitis—Pamidronate—osteoporosis	0.000695	0.00688	CcSEcCtD
Mebendazole—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	0.000682	0.00341	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—TUBA1B—osteoporosis	0.000662	0.00331	CbGpPWpGaD
Mebendazole—Rash—Zoledronate—osteoporosis	0.000636	0.00629	CcSEcCtD
Mebendazole—Gastrointestinal pain—Estradiol—osteoporosis	0.000635	0.00629	CcSEcCtD
Mebendazole—Dermatitis—Zoledronate—osteoporosis	0.000635	0.00629	CcSEcCtD
Mebendazole—Urticaria—Estradiol—osteoporosis	0.000617	0.00611	CcSEcCtD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000614	0.00308	CbGpPWpGaD
Mebendazole—Abdominal pain—Estradiol—osteoporosis	0.000614	0.00608	CcSEcCtD
Mebendazole—Rash—Conjugated Estrogens—osteoporosis	0.000612	0.00606	CcSEcCtD
Mebendazole—Dermatitis—Conjugated Estrogens—osteoporosis	0.000612	0.00605	CcSEcCtD
Mebendazole—CYP1A1—Oxidative Stress—SOD2—osteoporosis	0.000592	0.00296	CbGpPWpGaD
Mebendazole—Hypersensitivity—Estradiol—osteoporosis	0.000573	0.00567	CcSEcCtD
Mebendazole—CYP1A1—Oxidative Stress—GPX1—osteoporosis	0.000565	0.00283	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—RPL24—osteoporosis	0.000529	0.00265	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—GPD2—osteoporosis	0.00052	0.0026	CbGpPWpGaD
Mebendazole—CYP1A1—Tryptophan metabolism—CYP19A1—osteoporosis	0.000492	0.00247	CbGpPWpGaD
Mebendazole—Rash—Estradiol—osteoporosis	0.00049	0.00485	CcSEcCtD
Mebendazole—Dermatitis—Estradiol—osteoporosis	0.00049	0.00484	CcSEcCtD
Mebendazole—TUBA1A—p73 transcription factor network—MYC—osteoporosis	0.000483	0.00242	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—CCT2—osteoporosis	0.00047	0.00235	CbGpPWpGaD
Mebendazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.00047	0.00235	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—TLN1—osteoporosis	0.000465	0.00233	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—REN—osteoporosis	0.000447	0.00224	CbGpPWpGaD
Mebendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000438	0.00219	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.00041	0.00205	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.00041	0.00205	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—OXCT1—osteoporosis	0.000404	0.00202	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—TUBA1B—osteoporosis	0.0004	0.002	CbGpPWpGaD
Mebendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000398	0.00199	CbGpPWpGaD
Mebendazole—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000393	0.00197	CbGpPWpGaD
Mebendazole—CYP1A1—Arachidonic acid metabolism—GPX1—osteoporosis	0.000375	0.00188	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000373	0.00187	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.000369	0.00185	CbGpPWpGaD
Mebendazole—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000368	0.00184	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—PSMA2—osteoporosis	0.000366	0.00183	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—PSMA5—osteoporosis	0.000366	0.00183	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000358	0.00179	CbGpPWpGaD
Mebendazole—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000351	0.00176	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.000329	0.00165	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—CYP27A1—osteoporosis	0.000326	0.00163	CbGpPWpGaD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000323	0.00162	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000322	0.00161	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—RPL24—osteoporosis	0.000319	0.0016	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000302	0.00151	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—TLN1—osteoporosis	0.000281	0.00141	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—ACE—osteoporosis	0.000279	0.0014	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—REN—osteoporosis	0.00027	0.00135	CbGpPWpGaD
Mebendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.00027	0.00135	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000247	0.00124	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000247	0.00124	CbGpPWpGaD
Mebendazole—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000242	0.00121	CbGpPWpGaD
Mebendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000239	0.0012	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—PSMA2—osteoporosis	0.000221	0.00111	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—PSMA5—osteoporosis	0.000221	0.00111	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.00022	0.0011	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000218	0.00109	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000207	0.00104	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.000206	0.00103	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000196	0.000981	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000195	0.000976	CbGpPWpGaD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000194	0.000971	CbGpPWpGaD
Mebendazole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000193	0.000968	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—LEP—osteoporosis	0.000173	0.000867	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—CYP19A1—osteoporosis	0.000171	0.000858	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.000171	0.000856	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000171	0.000854	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—CYP19A1—osteoporosis	0.000169	0.000847	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—ACE—osteoporosis	0.000168	0.000843	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000161	0.000805	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000161	0.000804	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	0.000159	0.000798	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—osteoporosis	0.000159	0.000798	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000159	0.000795	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000158	0.000793	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000157	0.000785	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—POMC—osteoporosis	0.000149	0.000745	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—IGF1—osteoporosis	0.000143	0.000717	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000139	0.000694	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000134	0.000673	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	0.00013	0.00065	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000125	0.000627	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000118	0.000589	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—MYC—osteoporosis	0.000115	0.000578	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL1B—osteoporosis	0.000114	0.00057	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000109	0.000545	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000107	0.000533	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—LEP—osteoporosis	0.000105	0.000524	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—MYC—osteoporosis	0.000103	0.000517	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—POMC—osteoporosis	0.000103	0.000516	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PKM—osteoporosis	9.72e-05	0.000487	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—FDPS—osteoporosis	9.72e-05	0.000487	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.55e-05	0.000478	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PGLS—osteoporosis	9.21e-05	0.000461	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GPD2—osteoporosis	9.21e-05	0.000461	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—POMC—osteoporosis	8.99e-05	0.00045	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TGFB1—osteoporosis	8.84e-05	0.000443	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—IGF1—osteoporosis	8.64e-05	0.000433	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	8.44e-05	0.000422	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PNP—osteoporosis	8.43e-05	0.000422	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ATIC—osteoporosis	8.43e-05	0.000422	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	8.41e-05	0.000421	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	8.32e-05	0.000417	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TNF—osteoporosis	8.26e-05	0.000413	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PKM—osteoporosis	7.76e-05	0.000389	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—FDPS—osteoporosis	7.76e-05	0.000389	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GPD2—osteoporosis	7.36e-05	0.000368	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PGLS—osteoporosis	7.36e-05	0.000368	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	7.28e-05	0.000364	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—OXCT1—osteoporosis	7.17e-05	0.000359	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CA2—osteoporosis	7.17e-05	0.000359	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MGLL—osteoporosis	6.98e-05	0.00035	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—MYC—osteoporosis	6.97e-05	0.000349	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PNP—osteoporosis	6.73e-05	0.000337	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ATIC—osteoporosis	6.73e-05	0.000337	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.58e-05	0.00033	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MYC—osteoporosis	6.23e-05	0.000312	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—IDH2—osteoporosis	5.94e-05	0.000297	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—OXCT1—osteoporosis	5.72e-05	0.000286	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CA2—osteoporosis	5.72e-05	0.000286	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP27A1—osteoporosis	5.58e-05	0.000279	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MGLL—osteoporosis	5.58e-05	0.000279	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ACP5—osteoporosis	5.43e-05	0.000272	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.36e-05	0.000268	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—POMC—osteoporosis	5.07e-05	0.000254	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—TPI1—osteoporosis	5.05e-05	0.000253	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—FDPS—osteoporosis	4.78e-05	0.000239	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PKM—osteoporosis	4.78e-05	0.000239	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—P4HB—osteoporosis	4.75e-05	0.000238	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—IDH2—osteoporosis	4.74e-05	0.000237	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GAPDH—osteoporosis	4.66e-05	0.000233	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—RAP1A—osteoporosis	4.54e-05	0.000227	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GPD2—osteoporosis	4.53e-05	0.000227	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PGLS—osteoporosis	4.53e-05	0.000227	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP27A1—osteoporosis	4.46e-05	0.000223	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	4.38e-05	0.000219	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	4.36e-05	0.000218	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ACP5—osteoporosis	4.34e-05	0.000217	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PNP—osteoporosis	4.15e-05	0.000208	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ATIC—osteoporosis	4.15e-05	0.000208	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.09e-05	0.000205	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	4.08e-05	0.000204	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TPI1—osteoporosis	4.03e-05	0.000202	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.96e-05	0.000198	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—P4HB—osteoporosis	3.79e-05	0.00019	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GAPDH—osteoporosis	3.72e-05	0.000186	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ENO1—osteoporosis	3.67e-05	0.000184	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—RAP1A—osteoporosis	3.62e-05	0.000181	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PSMA5—osteoporosis	3.61e-05	0.000181	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PSMA2—osteoporosis	3.61e-05	0.000181	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—OXCT1—osteoporosis	3.53e-05	0.000176	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CA2—osteoporosis	3.53e-05	0.000176	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MGLL—osteoporosis	3.44e-05	0.000172	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP19A1—osteoporosis	2.93e-05	0.000147	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ENO1—osteoporosis	2.93e-05	0.000147	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—IDH2—osteoporosis	2.92e-05	0.000146	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PSMA2—osteoporosis	2.89e-05	0.000145	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PSMA5—osteoporosis	2.89e-05	0.000145	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.75e-05	0.000138	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ACP5—osteoporosis	2.67e-05	0.000134	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TPI1—osteoporosis	2.48e-05	0.000124	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ADCY5—osteoporosis	2.4e-05	0.00012	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GPX1—osteoporosis	2.39e-05	0.00012	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP19A1—osteoporosis	2.34e-05	0.000117	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—P4HB—osteoporosis	2.34e-05	0.000117	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GAPDH—osteoporosis	2.29e-05	0.000115	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—RAP1A—osteoporosis	2.23e-05	0.000112	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MTHFR—osteoporosis	2.2e-05	0.00011	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ADCY5—osteoporosis	1.91e-05	9.58e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GPX1—osteoporosis	1.91e-05	9.55e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ENO1—osteoporosis	1.81e-05	9.04e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PSMA2—osteoporosis	1.78e-05	8.9e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PSMA5—osteoporosis	1.78e-05	8.9e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—POMC—osteoporosis	1.76e-05	8.82e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MTHFR—osteoporosis	1.76e-05	8.81e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.44e-05	7.22e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—POMC—osteoporosis	1.41e-05	7.05e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ADCY5—osteoporosis	1.18e-05	5.9e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GPX1—osteoporosis	1.17e-05	5.88e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MTHFR—osteoporosis	1.08e-05	5.43e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—POMC—osteoporosis	8.67e-06	4.34e-05	CbGpPWpGaD
